Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Y Graham

Showing results (241-250 of 481) with videos related to

Pageof 49
Sort By:
Helicobacter|March 26, 2011
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?Ping I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
Best Practice & Research. Clinical Gastroenterology|July 2, 2013
Esophageal squamous cell carcinoma with special reference to its early stageMichio Shimizu, Giovanni Zaninotto, Koji Nagata, et al.
The Journal of Infectious Diseases|July 13, 2014
Reply to Kirby et alRobert L Atmar, Antone R Opekun, Mary K Estes, et al.
Gastroenterology|April 2, 2021
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical TrialKristina G Hulten, Linda B Lamberth, Ira N Kalfus, et al.
Journal of Digestive Diseases|July 24, 2010
Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCPFrancisco C Ramirez, Michael S Osato, David Y Graham, et al.
The American Journal of Gastroenterology|June 3, 2005
Obesity is an independent risk factor for GERD symptoms and erosive esophagitisHashem B El-Serag, David Y Graham, Jessie A Satia, et al.
Digestive Diseases and Sciences|March 17, 2018
An Investigation into the Recent Increase in Gastric Cancer in the USAMaya Balakrishnan, Rollin George, Ashish Sharma, et al.
Archives of Internal Medicine|October 11, 2002
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysisHashem B El-Serag, David Y Graham, Peter Richardson, et al.
Helicobacter|April 4, 2006
Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infectionsZhannat Z Nurgalieva, Zhannat Z Nugalieva, Antone R Opekun, et al.
Journal of Digestive Diseases|August 14, 2018
Enzyme therapy for functional bowel disease-like post-prandial distressDavid Y Graham, Gyanprakash A Ketwaroo, Mary E Money, et al.
Pageof 49

Showing results (241-250 of 481) with videos related to

Sort By:
Pageof 49
Helicobacter|March 26, 2011
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?Ping I Hsu, Deng-Chyang Wu, Jeng-Yih Wu, et al.
Best Practice & Research. Clinical Gastroenterology|July 2, 2013
Esophageal squamous cell carcinoma with special reference to its early stageMichio Shimizu, Giovanni Zaninotto, Koji Nagata, et al.
The Journal of Infectious Diseases|July 13, 2014
Reply to Kirby et alRobert L Atmar, Antone R Opekun, Mary K Estes, et al.
Gastroenterology|April 2, 2021
National and Regional US Antibiotic Resistance to Helicobacter pylori: Lessons From a Clinical TrialKristina G Hulten, Linda B Lamberth, Ira N Kalfus, et al.
Journal of Digestive Diseases|July 24, 2010
Addition of gentamicin to endoscopic retrograde cholangiopancreatography (ERCP) contrast medium towards reducing the frequency of septic complications of ERCPFrancisco C Ramirez, Michael S Osato, David Y Graham, et al.
The American Journal of Gastroenterology|June 3, 2005
Obesity is an independent risk factor for GERD symptoms and erosive esophagitisHashem B El-Serag, David Y Graham, Jessie A Satia, et al.
Digestive Diseases and Sciences|March 17, 2018
An Investigation into the Recent Increase in Gastric Cancer in the USAMaya Balakrishnan, Rollin George, Ashish Sharma, et al.
Archives of Internal Medicine|October 11, 2002
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysisHashem B El-Serag, David Y Graham, Peter Richardson, et al.
Helicobacter|April 4, 2006
Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infectionsZhannat Z Nurgalieva, Zhannat Z Nugalieva, Antone R Opekun, et al.
Journal of Digestive Diseases|August 14, 2018
Enzyme therapy for functional bowel disease-like post-prandial distressDavid Y Graham, Gyanprakash A Ketwaroo, Mary E Money, et al.
Pageof 49